<p>It is intended to provide a preventive/remedy for Alzheimer's disease. More specifically speaking, it is intended to provide a preventive/remedy for Alzheimer's disease and so on which contains a monoclonal antibody reacting specifically with a partial peptide in the C-terminal side of beta-amyloid or its derivative.</p>
申请公布号
WO2005025616(A1)
申请公布日期
2005.03.24
申请号
WO2004JP13397
申请日期
2004.09.08
申请人
TAKEDA PHARMACEUTICAL COMPANY LIMITED;SHOJI, MIKIO;ASAMI, ASANO;SUZUKI, NOBUHIRO
